Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody | Patent Number 08329172

US 08329172 B2
Application Number11840956
Publication NumberUS 20080038261 A1
Pendency5 years, 3 months, 27 days
Filled DateAug 18, 2007
Priority DateAug 11, 1998
Publication DateFeb 14, 2008
Expiration DateAug 11, 2018
Inventor/ApplicantsAntonio J. Grillo-López
ANTONIO J. GRILLO-LOPEZ
ExaminesSCHWADRON, RONALD B
Art Unit1644
Technology Center1600
Assignments
Biogen
Current
Biogen
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.